{
    "thread": {
        "uuid": "673cd2193871974543bdfac38171cf868ab0a1db",
        "url": "https://www.gurufocus.com/news/2798989/pfizer-declares-secondquarter-2025-dividend",
        "site_full": "www.gurufocus.com",
        "site": "gurufocus.com",
        "site_section": "https://www.gurufocus.com/rss.php",
        "site_categories": [
            "investing",
            "financial_news",
            "finance"
        ],
        "section_title": "GuruFocus New Articles",
        "site_title": "GuruFocus | Stock Market Research, Data and Tools",
        "title": "Pfizer Declares Second-Quarter 2025 Dividend",
        "title_full": "Pfizer Declares Second-Quarter 2025 Dividend",
        "published": "2025-04-24T00:07:29.684+03:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "US",
        "main_image": "https://static.gurufocus.com/images/global_logo_twitter_card.png",
        "performance_score": 0,
        "domain_rank": 8416,
        "domain_rank_updated": "2025-04-22T00:00:00.000+03:00",
        "licensing_agency": [],
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "673cd2193871974543bdfac38171cf868ab0a1db",
    "url": "https://www.gurufocus.com/news/2798989/pfizer-declares-secondquarter-2025-dividend",
    "ord_in_thread": 0,
    "author": "@gurufocus",
    "published": "2025-04-24T00:07:29.684+03:00",
    "title": "Pfizer Declares Second-Quarter 2025 Dividend",
    "text": "Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 second-quarter 2025 dividend on the company’s common stock, payable June 13, 2025, to holders of the Common Stock of record at the close of business on May 9, 2025. The second-quarter 2025 cash dividend will be the 346th consecutive quarterly dividend paid by Pfizer.\nAbout Pfizer: Breakthroughs That Change Patients’ Lives\nAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For 175 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at [www.Pfizer.com][.] In addition, to learn more, please visit us on [www.Pfizer.com] and follow us on X at [@Pfizer] and [@Pfizer News][,] [LinkedIn][,] [YouTube] and like us on Facebook at [Facebook.com/Pfizer][.]\nCategory: Finance\nView source version on businesswire.com: https://www.businesswire.com/news/home/20250423991317/en/\nFree Trial)",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "english",
    "sentiment": "positive",
    "categories": [
        "Economy, Business and Finance",
        "Health",
        "Social Issue"
    ],
    "topics": [
        "Economy, Business and Finance->business reporting and performance",
        "Economy, Business and Finance->financial service",
        "Economy, Business and Finance->investment and opinion pieces",
        "Health->health organisation"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [
        "https://www.businesswire.com/news/home/20250423991317/en/",
        "https://www.businesswire.com/news/home/20250423991317/en",
        "https://businesswire.com/news/home/20250423991317/en/"
    ],
    "entities": {
        "persons": [],
        "locations": [],
        "organizations": [
            {
                "name": "Pfizer Inc.",
                "sentiment": "negative",
                "tickers": []
            }
        ]
    },
    "syndication": {
        "syndicated": false,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "trust": {
        "categories": [],
        "bias": null,
        "source": {
            "type": null,
            "city": null,
            "state": null,
            "country": null,
            "domain_type": null,
            "agency": null,
            "organization_name": null
        }
    },
    "rating": null,
    "crawled": "2025-04-24T00:07:29.684+03:00",
    "updated": "2025-04-24T00:07:29.684+03:00"
}